389 related articles for article (PubMed ID: 25712922)
1. X-linked acrogigantism syndrome: clinical profile and therapeutic responses.
Beckers A; Lodish MB; Trivellin G; Rostomyan L; Lee M; Faucz FR; Yuan B; Choong CS; Caberg JH; Verrua E; Naves LA; Cheetham TD; Young J; Lysy PA; Petrossians P; Cotterill A; Shah NS; Metzger D; Castermans E; Ambrosio MR; Villa C; Strebkova N; Mazerkina N; Gaillard S; Barra GB; Casulari LA; Neggers SJ; Salvatori R; Jaffrain-Rea ML; Zacharin M; Santamaria BL; Zacharieva S; Lim EM; Mantovani G; Zatelli MC; Collins MT; Bonneville JF; Quezado M; Chittiboina P; Oldfield EH; Bours V; Liu P; W de Herder W; Pellegata N; Lupski JR; Daly AF; Stratakis CA
Endocr Relat Cancer; 2015 Jun; 22(3):353-67. PubMed ID: 25712922
[TBL] [Abstract][Full Text] [Related]
2. Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.
Iacovazzo D; Caswell R; Bunce B; Jose S; Yuan B; Hernández-Ramírez LC; Kapur S; Caimari F; Evanson J; Ferraù F; Dang MN; Gabrovska P; Larkin SJ; Ansorge O; Rodd C; Vance ML; Ramírez-Renteria C; Mercado M; Goldstone AP; Buchfelder M; Burren CP; Gurlek A; Dutta P; Choong CS; Cheetham T; Trivellin G; Stratakis CA; Lopes MB; Grossman AB; Trouillas J; Lupski JR; Ellard S; Sampson JR; Roncaroli F; Korbonits M
Acta Neuropathol Commun; 2016 Jun; 4(1):56. PubMed ID: 27245663
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.
Rostomyan L; Daly AF; Petrossians P; Nachev E; Lila AR; Lecoq AL; Lecumberri B; Trivellin G; Salvatori R; Moraitis AG; Holdaway I; Kranenburg-van Klaveren DJ; Chiara Zatelli M; Palacios N; Nozieres C; Zacharin M; Ebeling T; Ojaniemi M; Rozhinskaya L; Verrua E; Jaffrain-Rea ML; Filipponi S; Gusakova D; Pronin V; Bertherat J; Belaya Z; Ilovayskaya I; Sahnoun-Fathallah M; Sievers C; Stalla GK; Castermans E; Caberg JH; Sorkina E; Auriemma RS; Mittal S; Kareva M; Lysy PA; Emy P; De Menis E; Choong CS; Mantovani G; Bours V; De Herder W; Brue T; Barlier A; Neggers SJ; Zacharieva S; Chanson P; Shah NS; Stratakis CA; Naves LA; Beckers A
Endocr Relat Cancer; 2015 Oct; 22(5):745-57. PubMed ID: 26187128
[TBL] [Abstract][Full Text] [Related]
4. Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.
Trivellin G; Daly AF; Faucz FR; Yuan B; Rostomyan L; Larco DO; Schernthaner-Reiter MH; Szarek E; Leal LF; Caberg JH; Castermans E; Villa C; Dimopoulos A; Chittiboina P; Xekouki P; Shah N; Metzger D; Lysy PA; Ferrante E; Strebkova N; Mazerkina N; Zatelli MC; Lodish M; Horvath A; de Alexandre RB; Manning AD; Levy I; Keil MF; Sierra Mde L; Palmeira L; Coppieters W; Georges M; Naves LA; Jamar M; Bours V; Wu TJ; Choong CS; Bertherat J; Chanson P; Kamenický P; Farrell WE; Barlier A; Quezado M; Bjelobaba I; Stojilkovic SS; Wess J; Costanzi S; Liu P; Lupski JR; Beckers A; Stratakis CA
N Engl J Med; 2014 Dec; 371(25):2363-74. PubMed ID: 25470569
[TBL] [Abstract][Full Text] [Related]
5. Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome.
Naves LA; Daly AF; Dias LA; Yuan B; Zakir JC; Barra GB; Palmeira L; Villa C; Trivellin G; Júnior AJ; Neto FF; Liu P; Pellegata NS; Stratakis CA; Lupski JR; Beckers A
Endocrine; 2016 Feb; 51(2):236-44. PubMed ID: 26607152
[TBL] [Abstract][Full Text] [Related]
6. An orphan G-protein-coupled receptor causes human gigantism and/or acromegaly: Molecular biology and clinical correlations.
Trivellin G; Hernández-Ramírez LC; Swan J; Stratakis CA
Best Pract Res Clin Endocrinol Metab; 2018 Apr; 32(2):125-140. PubMed ID: 29678281
[TBL] [Abstract][Full Text] [Related]
7. X-LAG: How did they grow so tall?
Beckers A; Rostomyan L; Potorac I; Beckers P; Daly AF
Ann Endocrinol (Paris); 2017 Jun; 78(2):131-136. PubMed ID: 28457479
[TBL] [Abstract][Full Text] [Related]
8. Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism.
Franke M; Daly AF; Palmeira L; Tirosh A; Stigliano A; Trifan E; Faucz FR; Abboud D; Petrossians P; Tena JJ; Vitali E; Lania AG; Gómez-Skarmeta JL; Beckers A; Stratakis CA; Trivellin G
Am J Hum Genet; 2022 Apr; 109(4):553-570. PubMed ID: 35202564
[TBL] [Abstract][Full Text] [Related]
9. Familial X-Linked Acrogigantism: Postnatal Outcomes and Tumor Pathology in a Prenatally Diagnosed Infant and His Mother.
Wise-Oringer BK; Zanazzi GJ; Gordon RJ; Wardlaw SL; William C; Anyane-Yeboa K; Chung WK; Kohn B; Wisoff JH; David R; Oberfield SE
J Clin Endocrinol Metab; 2019 Oct; 104(10):4667-4675. PubMed ID: 31166600
[TBL] [Abstract][Full Text] [Related]
10. GHRH excess and blockade in X-LAG syndrome.
Daly AF; Lysy PA; Desfilles C; Rostomyan L; Mohamed A; Caberg JH; Raverot V; Castermans E; Marbaix E; Maiter D; Brunelle C; Trivellin G; Stratakis CA; Bours V; Raftopoulos C; Beauloye V; Barlier A; Beckers A
Endocr Relat Cancer; 2016 Mar; 23(3):161-70. PubMed ID: 26671997
[TBL] [Abstract][Full Text] [Related]
11. [Overgrowth in children and in adults: novel clinical view, novel genes, novel phenotypes].
Lebl J; Plachý L; Bláhová K; Elblová L; Fencl F; Koloušková S; Průhová Š
Cas Lek Cesk; 2017; 156(5):233-240. PubMed ID: 28992707
[TBL] [Abstract][Full Text] [Related]
12. Gigantism: X-linked acrogigantism and GPR101 mutations.
Iacovazzo D; Korbonits M
Growth Horm IGF Res; 2016; 30-31():64-69. PubMed ID: 27743704
[TBL] [Abstract][Full Text] [Related]
13. The causes and consequences of pituitary gigantism.
Beckers A; Petrossians P; Hanson J; Daly AF
Nat Rev Endocrinol; 2018 Dec; 14(12):705-720. PubMed ID: 30361628
[TBL] [Abstract][Full Text] [Related]
14. Somatic GPR101 Duplication Causing X-Linked Acrogigantism (XLAG)-Diagnosis and Management.
Rodd C; Millette M; Iacovazzo D; Stiles CE; Barry S; Evanson J; Albrecht S; Caswell R; Bunce B; Jose S; Trouillas J; Roncaroli F; Sampson J; Ellard S; Korbonits M
J Clin Endocrinol Metab; 2016 May; 101(5):1927-30. PubMed ID: 26982009
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment with octreotide LAR and pegvisomant in patients with pituitary gigantism: clinical evaluation and genetic screening.
Mangupli R; Rostomyan L; Castermans E; Caberg JH; Camperos P; Krivoy J; Cuauro E; Bours V; Daly AF; Beckers A
Pituitary; 2016 Oct; 19(5):507-14. PubMed ID: 27287035
[TBL] [Abstract][Full Text] [Related]
16. Pituitary gigantism: Causes and clinical characteristics.
Rostomyan L; Daly AF; Beckers A
Ann Endocrinol (Paris); 2015 Dec; 76(6):643-9. PubMed ID: 26585365
[TBL] [Abstract][Full Text] [Related]
17. Pituitary gigantism: update on molecular biology and management.
Lodish MB; Trivellin G; Stratakis CA
Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):72-80. PubMed ID: 26574647
[TBL] [Abstract][Full Text] [Related]
18. Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects.
Daly AF; Yuan B; Fina F; Caberg JH; Trivellin G; Rostomyan L; de Herder WW; Naves LA; Metzger D; Cuny T; Rabl W; Shah N; Jaffrain-Rea ML; Zatelli MC; Faucz FR; Castermans E; Nanni-Metellus I; Lodish M; Muhammad A; Palmeira L; Potorac I; Mantovani G; Neggers SJ; Klein M; Barlier A; Liu P; Ouafik L; Bours V; Lupski JR; Stratakis CA; Beckers A
Endocr Relat Cancer; 2016 Apr; 23(4):221-33. PubMed ID: 26935837
[TBL] [Abstract][Full Text] [Related]
19. Gigantism with pituitary macroadenoma: an unusual variant of McCune-Albright syndrome.
Queirolo S; Gallarotti F; Capuano E; Garrè ML; Spaziante R; Di Battista E
J Pediatr Endocrinol Metab; 2009 Feb; 22(2):177-9. PubMed ID: 19449675
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
